首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝素类药物防治阿尔采末病的研究进展
引用本文:郝丽娜,赵孝林,吴学新.肝素类药物防治阿尔采末病的研究进展[J].齐鲁药事,2014(11):657-660.
作者姓名:郝丽娜  赵孝林  吴学新
作者单位:山东大学齐鲁儿童医院药学部,山东 济南,250022
摘    要:本文分析了阿尔采末病(AD)的病理机制,对肝素类药物神经保护机制的进展进行了综述。阐明了肝素类药物可通过调节IP3受体介导的细胞内钙释放,影响淀粉样蛋白(Aβ)沉积及其毒性、调节tau蛋白的磷酸化状态,保护胆碱能神经元等发挥神经保护作用,从而延缓AD的发生与发展。

关 键 词:肝素  阿尔采末病(AD)  细胞内钙  淀粉样蛋白  tau蛋白  胆碱能神经元

ResearcH progress oN tHe effects of HepariNs oN AlzHeimer's disease
HAO Li-na,ZHAO Xiao-lin,WU Xue-xin.ResearcH progress oN tHe effects of HepariNs oN AlzHeimer's disease[J].qilu pharmaceutical affairs,2014(11):657-660.
Authors:HAO Li-na  ZHAO Xiao-lin  WU Xue-xin
Institution:HAO Li-na;ZHAO Xiao-lin;WU Xue-xin;Department of Pharmay,Qilu Children’s Hospital of Shandong University;
Abstract:This paper analyzed the pathological mechanisms of AD,reviewed the progress of the mechanisms of the neu-roprotective effect of heparin and its derivatives,clarified that heparin and its derivatives had neuroprotective effects through regulating IP3Rs-mediated intracellular calcium release,inhibiting Aβdeposition and Aβ-induced toxicity,regulating the tau protein phosphorylation state,and protecting cholinergic neurons,thereby delayed the occurrence and development of AD.
Keywords:Heparin  Alzheimer's disease  Intracellular calcium  Aβ(β - amyloid peptide )  Tau protein  Cholinergic neurons
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号